FDA Approves Experimental Zika Test To Be Used On Blood Donations In Areas With Active Transmission

New York Times: FDA Clears Use of New Test to Screen Blood Donations for Zika
“The Food and Drug Administration announced Wednesday that it would allow the use of an experimental test to screen blood donations for contamination with the Zika virus…” (Saint Louis, 3/30).

Reuters: FDA permits use of Roche test to screen donated blood for Zika
“…The test, manufactured by a New Jersey-based unit of Swiss drugmaker Roche Holding AG, may be used for screening donated blood in areas with active mosquito-borne transmission of Zika virus, the FDA said…” (Grover, 3/30).

Wall Street Journal: FDA Allows Zika Test for Blood Donations
“…Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the screening test is an important step in maintaining the blood supply’s safety, especially in U.S. territories experiencing active transmission…” (Steele, 3/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.